{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:26:28Z","timestamp":1789500388499,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jneuroim.2025.578665","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T19:10:33Z","timestamp":1749496233000},"page":"578665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The immunology and neuropathology of the autoimmune nodopathies"],"prefix":"10.1016","volume":"406","author":[{"given":"Claire Bergstrom","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janev","family":"Fehmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jneuroim.2025.578665_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01099096","article-title":"The node of Ranvier in experimental allergic neuritis: an electron microscope study","volume":"4","author":"Allt","year":"1975","journal-title":"J. Neurocytol."},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578665_bb0010","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000817","article-title":"Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy","volume":"7","author":"Appeltshauser","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578665_bb0015","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/brain\/awac418","article-title":"Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage","volume":"146","author":"Appeltshauser","year":"2023","journal-title":"Brain"},{"issue":"S3","key":"10.1016\/j.jneuroim.2025.578665_bb0020","first-page":"O422","article-title":"CD27+IgD\u2212 memory B-cells produce germline-like NF155 & NF186 autoantibodies in a Pan-Neurofascin autoimmune Nodopathy patient","volume":"29","author":"Bergstrom Johnson","year":"2024","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578665_bb0025","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1212\/WNL.0000000000004773","article-title":"Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies","volume":"90","author":"Burnor","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578665_bb0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ana.27142","article-title":"Long-term follow up in anti-Contactin-1 autoimmune Nodopathy","volume":"97","author":"Caballero-\u00c1vila","year":"2025","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578665_bb0035","article-title":"Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype","volume":"1","author":"Cortese","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578665_bb0040","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000763","article-title":"Antibodies to nodal\/paranodal proteins in paediatric immune-mediated neuropathy","volume":"7","author":"De Simoni","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"issue":"7","key":"10.1016\/j.jneuroim.2025.578665_bb0045","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy","volume":"140","author":"Delmont","year":"2017","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.jneuroim.2025.578665_bb0050","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1007\/s00415-020-10041-z","article-title":"Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera","volume":"267","author":"Delmont","year":"2020","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578665_bb0055","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ajpath.2012.06.034","article-title":"Antibodies to Gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier","volume":"181","author":"Devaux","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578665_bb0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578665_bb0065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"issue":"Pt 10","key":"10.1016\/j.jneuroim.2025.578665_bb0070","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/brain\/aww189","article-title":"Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy","volume":"139","author":"Doppler","year":"2016","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578665_bb0075","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/jnnp-2018-318170","article-title":"Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies","volume":"89","author":"Doppler","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578665_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12974-019-1462-z","article-title":"Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model","volume":"16","author":"Doppler","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578665_bb0085","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1212\/NXI.0000000000000771","article-title":"Contactin-1 autoimmunity: serologic, neurologic, and pathologic correlates","volume":"7","author":"Dubey","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.jneuroim.2025.578665_bb0090","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/jnnp-2021-326343","article-title":"IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality","volume":"92","author":"Fehmi","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578665_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281156","article-title":"Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis","volume":"18","author":"Fehmi","year":"2023","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jneuroim.2025.578665_bb0100","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/dmcn.15493","article-title":"Antineurofascin IgG2-associated paediatric autoimmune nodopathy","volume":"65","author":"Harris","year":"2023","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.jneuroim.2025.578665_bb0105","doi-asserted-by":"crossref","first-page":"1189734","DOI":"10.3389\/fimmu.2023.1189734","article-title":"Different binding and pathogenic effect of neurofascin and contactin-1 autoantibodies in autoimmune nodopathies","volume":"14","author":"Hecker","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578665_bb0110","doi-asserted-by":"crossref","first-page":"e200014","DOI":"10.1212\/NXI.0000000000200014","article-title":"IgG4 Valency modulates the pathogenicity of anti-Neurofascin-155 IgG4 in autoimmune Nodopathy","volume":"9","author":"Jentzer","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"8","key":"10.1016\/j.jneuroim.2025.578665_bb0115","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","article-title":"Anti-neurofascin antibody in patients with combined central and peripheral demyelination","volume":"81","author":"Kawamura","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578665_bb0120","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578665_bb0125","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410440210","article-title":"IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome","volume":"44","author":"Kuwabara","year":"1998","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578665_bb0130","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1007\/s00415-023-11759-2","article-title":"Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study","volume":"270","author":"Liu","year":"2023","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578665_bb0135","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/acn3.51775","article-title":"Clinical profile of autoimmune nodopathy with anti-neurofascin 186 antibody","volume":"10","author":"Liu","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578665_bb0140","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/brain\/aww062","article-title":"Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects","volume":"139","author":"Manso","year":"2016","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578665_bb0145","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1172\/JCI124694","article-title":"Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo","volume":"129","author":"Manso","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578665_bb0150","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1212\/WNL.0000000000009189","article-title":"Antibodies against nodo-paranodal proteins are not present in genetic neuropathies","volume":"95","author":"Mart\u00edn-Aguilar","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578665_bb0155","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001098","article-title":"Clinical and laboratory features in anti-NF155 autoimmune Nodopathy","volume":"9","author":"Mart\u00edn-Aguilar","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578665_bb0160","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12974-017-0996-1","article-title":"Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15","volume":"14","author":"Martinez-Martinez","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2025.578665_bb0165","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/brain\/awq119","article-title":"Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice","volume":"133","author":"McGonigal","year":"2010","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578665_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jns.12520","article-title":"The endogenous calpain inhibitor calpastatin attenuates axon degeneration in murine Guillain-Barr\u00e9 syndrome","volume":"28","author":"McGonigal","year":"2023","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578665_bb0175","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Group for the CCS. Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain"},{"issue":"23","key":"10.1016\/j.jneuroim.2025.578665_bb0180","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578665_bb0185","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/mus.28239","article-title":"The difference in nerve ultrasound and motor nerve conduction studies between autoimmune nodopathy and chronic inflammatory demyelinating polyneuropathy","volume":"70","author":"Niu","year":"2024","journal-title":"Muscle Nerve"},{"issue":"339","key":"10.1016\/j.jneuroim.2025.578665_bb0190","article-title":"Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy","volume":"15","author":"Ogata","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578665_bb0195","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/brain\/awab014","article-title":"Antibodies to the Caspr1\/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"144","author":"Pascual-Go\u00f1i","year":"2021","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578665_bb0200","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awq372","article-title":"Neurofascin as target of autoantibodies in Guillain\u2013Barr\u00e9 syndrome","volume":"134","author":"Pr\u00fcss","year":"2011","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578665_bb0205","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.jneuroim.2025.578665_bb0210","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578665_bb0215","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins","volume":"2","author":"Querol","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"19","key":"10.1016\/j.jneuroim.2025.578665_bb0220","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.3390\/jcm13195721","article-title":"Antibody-mediated Nodo- and Paranodopathies","volume":"13","author":"Quinot","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578665_bb0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41583-020-00406-8","article-title":"Mechanisms of node of Ranvier assembly","volume":"22","author":"Rasband","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578665_bb0230","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","article-title":"The unique properties of IgG4 and its roles in health and disease","volume":"23","author":"Rispens","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578665_bb0235","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200295","article-title":"Different patterns of autoantibody secretion by peripheral blood mononuclear cells in autoimmune Nodopathies","volume":"11","author":"Rohrbacher","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"24","key":"10.1016\/j.jneuroim.2025.578665_bb0240","doi-asserted-by":"crossref","first-page":"e2392","DOI":"10.1212\/WNL.0000000000012932","article-title":"Neurofascin-155 immunoglobulin subtypes: Clinicopathologic associations and neurologic outcomes","volume":"97","author":"Shelly","year":"2021","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578665_bb0245","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000603","article-title":"Anti\u2013pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy","volume":"6","author":"Stengel","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578665_bb0250","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1002\/mus.26392","article-title":"\u201cNeuro-renal syndrome\u201d related to anti-contactin-1 antibodies","volume":"59","author":"Taieb","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2025.578665_bb0255","doi-asserted-by":"crossref","first-page":"1021513","DOI":"10.3389\/fimmu.2023.1021513","article-title":"Effect of monovalency on anti-contactin-1 IgG4","volume":"14","author":"Taieb","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.jneuroim.2025.578665_bb0260","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.clinph.2013.03.025","article-title":"Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies","volume":"124","author":"Uncini","year":"2013","journal-title":"Clin. Neurophysiol."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578665_bb0265","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/jns.12455","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force\u2014second revision","volume":"26","author":"Van den Bergh","year":"2021","journal-title":"J. Peripheral. Nervous. Sys."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578665_bb0270","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1007\/s10072-021-05101-9","article-title":"From PNS to CNS: characteristics of anti-neurofascin 186 neuropathy in 16 cases","volume":"42","author":"Xie","year":"2021","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578665_bb0275","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200081","article-title":"Anti-LGI4 antibody is a novel Juxtaparanodal autoantibody for chronic inflammatory demyelinating polyneuropathy","volume":"10","author":"Zhang","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflam."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T21:53:40Z","timestamp":1753134820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825001468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":55,"alternative-id":["S0165572825001468"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578665","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunology and neuropathology of the autoimmune nodopathies","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578665"}}